Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CDIOthis companyCardio Diagnostics Holdings, Inc.	$1.65	-0.73×	0.68×	320.16×	-0.05×	34.3%	100.0%	-43737.5%	-43832.5%	-93.2%	-84.5%	-124.6%	0.1×	0.73×	-438.08×	9.79×	0.0%	1	-1.62	3	B
BCDABioCardia, Inc.	$0.89	-1.02×	9.31×	0×	-0.82×	-76.9%	0.0%	0.0%	0.0%	-919.3%	-581.7%	-89.3%	0.59×	0.25×	0×	1.12×	0.0%	1	-51.25	2	C
CELZCreative Medical Technology Holdings, Inc.	$0.61	-0.78×	0.62×	778.38×	0.42×	371.4%	63.4%	-102380.2%	-99916.8%	-79.8%	-81.5%	-125.4%	0×	1.2×	0×	25.97×	0.0%	1	-10.71	2	B-
IBOImpact BioMedical Inc.	$4.11	-1.33×	1.26×	497.66×	-1.27×	-100.4%	-1225.0%	-13343.8%	-36993.8%	-93.9%	-21.6%	-11.9%	0×	0×	-5.38×	0.35×	0.0%	4	2.31	2	C+
MTNBMatinas BioPharma Holdings, Inc.	$1.20	-0.29×	0.66×	0×	-0.06×	415.1%	0.0%	0.0%	0.0%	-214.2%	-108.1%	-218.6%	0.28×	0.27×	0×	2.79×	0.0%	1	-94.31	3	B-
TCRTAlaunos Therapeutics, Inc.	$1.77	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
Peer median	—	-1.02×	1.26×	497.66×	-0.82×	-76.9%	0.0%	-13343.8%	-36993.8%	-194.0%	-108.1%	-89.3%	0×	0.27×	0×	2.45×	0.0%	1	-51.25	2	—